from genetic study to clinical trials - kitasato-u.ac.jp · 2006-04-17 · 2 pharmacogenetics/...
Post on 11-Mar-2020
4 Views
Preview:
TRANSCRIPT
1
From Genetic Study to Clinical TrialsFrom Genetic Study to Clinical Trials
Chao Agnes Hsiung, Ph.D.
Division of Biostatistics and BioinformaticsNational Health Research Institutes
Taiwan
Chao Agnes Hsiung, Ph.DChao Agnes Hsiung, Ph.D..
Division of Biostatistics and BioinformaticsNational Health Research Institutes
Taiwan
2
Pharmacogenetics/ Pharmacogenomics
Recent advances in molecular biology and pharmacogenetics have contributed substantially to understanding of the genetic control of the metabolism as well as the effect of drugs.As an example, Asian patients, in general, respond to lower doses of antidepressants than those recommended based on studies involving Caucasian subjects.One of the mechanism responsible for such differential treatment responses and side effect profiles lies in genetic differences that alter the activity of CYP450 that metabolize antidepressants.
3
Pharmacogenetics/ Pharmacogenomics
Research data suggest that up to 70% Asian posses CYP2D6 and CYP2C19 unique alleles that slow down these enzyme activity (Lin et. Al. 1996,1994 ect).As another example, most patients with non-small-cell lung cancer (NSCLC) have no response to the tyrosine kinase inhibitor gefitinib (Iressa), which targets the epidermal growth factor receptor (EGFR). However, about 10% of patients have a rapid and dramatic clinical response.A subgroups of patients with non-small-cell lung caner have specific mutations in the EGFR gene, which correlate with clinical responsiveness to the Iressa.
4
Pharmacogenetics/ Pharmacogenomics
Screening for such mutations in lung cancers may identify patients who will have a response to Iressa. (NEJM 2004)Treatment with the EGFR kinase inhibitor gefitinib (Iressa) causes tumor regression in some patients with NSCLC, more frequently in Japan than in U.S..Somatic mutations of the EGFR were found in 15/58 unselected tumors from Japan and 1/61 for the US. (Science 2004)EGFR mutations in lung cancer: correlate with clinical response to Gefitinib therapy With progress in pharmacogenetics, some tools enable us to systematically examine factors that determine inter-individual as well as cross-ethnic variations in drug response
5
Design of Future Clinical Trials
Before a sensible clinical trial based on pharmacogenomics studies is designed, genetic studies would be of some help.
6
An International Collaborative Genetic Study
SAPPHIReNational Health Research Institutes (NHRI) and fourmedical centers (National Taiwan University Hospital, Veteran General Hospital- Taipei, VGH-Taichung and Tri-Service General Hospital) in Taiwan havecollaborated with Stanford University, Pacific HealthResearch Institutes at Hawaii on the study SAPPHIRe.
7
遺傳研究遺傳研究 -- SAPPHIReSAPPHIRe
SStanford
AAsian
PPacific
PProgram in
HHypertension and
IInsulin
ReResistance
8
Objectives
To map and identify major genetic loci underlying hypertension in Chinese and JapaneseTo study interactions between genetic and non-genetic determinants of hypertension in defined populations
9
A Gene Mapping Study for Hypertension
Hypertension is known to be a complex
disease with genes and environmental
factors interacting to control risk of this
disease
We have built up an infrastructure to
facilitate the gene-mapping study
10
Infrastructure of SAPPHIReInfrastructure of SAPPHIRe
SAPPHIReSAPPHIRe
Administrative Core
Administrative Core
DataCoordinating
Center
DataCoordinating
Center
Laboratory Center
Laboratory Center
GeneticsCenter
GeneticsCenter
ClinicalField
Center
ClinicalField
Center
StanfordCenter
StanfordCenter
TaiwanCenter
TaiwanCenter
TaiwanCenter
TaiwanCenter
HonoluluCenter
HonoluluCenter
San FranciscoBay Area CenterSan Francisco
Bay Area Center
11
Study Population
Hawaii, San Francisco Bay Area, Taiwan
1318 sib pairs who are Japanese or Chinese, 35 to 60 years old and who both have hypertension or one is hypertensive and one is hypotensive
Pedigrees with hypertension
12
Measured Variables
Demographic: age, gender, ethnicity, educationAnthropometry: height, weight, hip and waist circumferenceClinical/Biochemical: SBP, DBP, HDL, triglycerides, total cholesterol, OGTT, medicationsBehavioral: physical activity, smoking, alcohol intakeGenetic: 390 evenly spaced microsatellite markers for linkage analysis and many candidate genes for association studies
13
Hypertension as a Complex Disease
Hypertension is a major health problem, and represents a major risk factor for stroke, myocardial infarction, and renal disease.Hypertension often occurs in combination with other metabolic complications such as hyperlipidemia, obesity and insulin resistance.The combined disorder is often called the metabolic syndrome.
14
Some Study Topics
Try to identify chromosomal regions that may harbor genes influencing blood pressure, lipids or insulin resistanceIs the candidate gene studied (such as PPARγ, Alsosterone Synthase etc) associated with hypertension/insulin resistance? (How do the different genotypes affect blood pressure, insulin resistance?)
15
Association Studies (1) —Sibling based control study
Eliminate some environmental confounding factors.PPAR γ2– Peroxisome proliferator activated receptor Pro12Ala
polymorphism, The most common variant is the C -> G substitution at codon 12 causing an Alanine substitution for Proline
– Localized at 3P25– “A“ variant siblings tend to have lower level of fasting
glucose (p=0.0018) and lower glucose levels at 1 hour (p=0.00258)
following oral glucose loading (after adjusting for age, gender and body mass index) to be more insulin sensitive
16
Association Studies (2) — Genetic Heterogeneity
Test whether the nucleotide variation in HUT2 (SNPs) were
associated with BP variation.
HUT2 — kidney specific human urea transporter
– 2 SNPs result in Valine/Isoleucine and Alanine/Threonine
amino acid substitutions at position 227 and 357 in the
HUT2 ORF
– Isoleucine 227 and Alanine 357 alleles were associated
with low diastolic BP in men but not in women.
17
Association Studies (3) — Gene-gene interaction
Adiponectin gene– T94G in exon 2– T allele of adiponectin gene was associated with a
higher insulin level at 1 hour in oral glucose tolerance tests (OGTT) (p=0.0008)
– Significant interaction between adiponectin & PPARγ2in fasting insulin level, insulin levels at 2 hours in OGTT.
– Adiponectin G allele and PPARγ2 Ala12 allele are more insulin sensitive.
18
Candidate genes approachStudying SNP genotyping data for
promising spots
Genome-wide scan approachImproving the power of linkage
analysis in a sibpair design
Candidate genes approachCandidate genes approachStudying SNP genotyping data for
promising spots
GenomeGenome--wide scan approachwide scan approachImproving the power of linkage
analysis in a sibpair design
19
Study DesignThe study design was based on “ ascertaining sibpairs with extremely discordant or highly concordant phenotypes to obtain greater power to detect linkage ” (Risch & Zhang 1995, 96)
We suggest a systematic way to decide how to select discordant sibpairs or concordant sibpairs in linkage analysis based on their phenotype trait values.
We also propose a multipoint linkage analysis method which outperforms existing methods under the situationof linkage disequilibrium.
20
Genome-Scan Linkage Studies
There is a great ethnic heterogeneity of the genetic influence on metabolic variable levels.
It would be interesting to conduct a genome-wide scan to identify QTL influencing metabolic phenotypes in Chinese and Japanese population recruited in SAPPHIRe.
21
Likelihood-ratio tests were used to test of no linkage (i.e., the variance component due to the QTL being 0).
LOD (log of odds) scores = log10(LR) LOD ≥ 3.3: genome-wide significance for evidence of linkageLOD ≥ 1.9: suggestive evidence for linkage
likelihood of the estimated variance component due to the QTLThe likelihood ratio(LR)
likelihood of the variance component = 0 =
22
Linkage Studies
Linkage studies based on genome-wide scan data on ~400 microsatellite markers. LOD score > 4 was obtained for fasting insulin levels in Chinese.
23
Linkage study -Genome-Wide Scan
24
Candidate genes approachStudying SNP genotyping data for
promising spots
Genome-wide scan approachImproving the power of linkage
analysis in a sibpair design
Candidate genes approachCandidate genes approachStudying SNP genotyping data for
promising spots
GenomeGenome--wide scan approachwide scan approachImproving the power of linkage
analysis in a sibpair design
25
Association Between Single Nucleotide Polymorphisms in Protein Tyrosine Phosphatase 1β and Hypertension
Protein Tyrosine Phosphatase-1β (PTP1B) is a primary target in the search for genetic variations in patients with metabolic syndrome.
PTP1B
Insulin and leptinsignaling pathway
26
27
PTP-1β
The importance of PTP-1β for several metabolic pathways has been illustrated in mice deficient for this specific phosphatase.These animals had lower blood glucose concentrations and reduced circulating insulin levels when compared to their normal littermates.On a high-fat diet, PTP-1β deficient mice were resistant to weight gain, and remained insulin-sensitive, while their wild-type littermates became insulin resistant and obese.
28
PTPN1
Investigate the possible role of genetic variation in PTPN1 on the development of hypertension, hyperlipidemia, and obesity.Whether genetic variation in the human PTPN1 gene was associated with blood pressure, plasma lipid levels, or body mass index (BMI) as a measure of obesity.
29
Positions of all SNPs Identifies
1 2 3 4 5 6 7 8 9 1050,772 3,515 3,310 6,038 3,765
538 373 1,338 1,231
g.-7077G>C
g.-4022G>A
g.8235G>T
g.54281T>A
g.58585T>C
g.69220T>C
g.6930C>T
g.10985A>G
g.56860C>A
g.64840T>C
g.67543A>G
g.70139G>T
30
SNP Allele Frequencies
Minor Allele Frequency SNP Name dbSNP Chinese Japanese
g.-7077 G>C 29.4% 24.9% g.-4022 G>A rs6012953 32.8% 27.6% g.8235 G>T 39.0% 25.6% g.54281 T>A 35.1% 35.7% g.58585 T>C rs2038526 31.8% 34.1% g.69220 T>C rs2282146 19.6% 20.4%
Obtained complete genotyping data from 1553 subjects from 672 families for these six SNPs
31
Pairwise Linkage Disequilibrium (LD)| D´|: D(AB) = P(AB) - P(A)P(B)
standardized
g.-7
077G
>C
g.-4
022G
>C
g.82
35G
>T
g.54
281T
>A
g.58
585T
>C
g.69
220T
>C
g.-7077G>C 0.88 1.00 0.35 0.51 0.23 g.-7077G>C
g.-4022G>C 0.75 0.53 0.76 0.47 0.13 g.-4022G>C
g.8235G>T 0.86 0.63 0.42 0.49 0.35 g.8235G>T
g.54281T>A 0.70 0.92 0.33 0.92 0.55 g.54281T>A
g.58585T>C 0.63 0.53 0.27 1.00 0.70 g.58585T>C
g.69220T>C 0.38 0.33 0.23 0.60 0.79 g.69220T>C
g.-7
077G
>C
g.-4
022G
>C
g.82
35G
>T
g.54
281T
>A
g.58
585T
>C
g.69
220T
>C
Chinese
Japanese
32
Estimated Common HaplotypesChinese Japanese
37.8% 47.9% Haplotype 1
11.3% 6.7% Haplotype 2
7.0% 6.2% Haplotype 3
6.1% 8.1% Haplotype 4
5.6% 5.5% Haplotype 5
5.3% 3.8% Haplotype 6
5.1% 6.7% Haplotype 7
5.0% 3.6% Haplotype 8
83.2% 88.5%
33
Haplotype Analysis
1 2 3 4 5 6
g.-7077 G>C 0.66840.8238
g.-4022 G>A 0.9042 0.1410.5972 0.175
g.8235 G>T 0.7258 0.216 0.02820.173 0.0804 0
g.54281 T>A 0.0534 0.0084 0.31640.0092 0.2722
g.58585 T>C 0.7656 0.00360.0826
g.69220 T>C 0.0676
B. Chinese
34
Haplotype Analysis
1 2 3 4 5 6
g.-7077 G>C 0.01620.1348
g.-4022 G>A 0.132 0.23080.081 0.212
g.8235 G>T 0.0126 0.0248 00.0064 0.2022 0.3106
g.54281 T>A 0.1214 0.0048 0.01280.2448 0.0296
g.58585 T>C 0.2516 0.0920.0494
g.69220 T>C 0.5112
C. Japanese
35
Conclusion and Discussion
This analysis suggests a role of PTP-1β in essential hypertension and lipid profile in Asians.Examine the relationship of the different genes and their combined role in glucose and lipid metabolism as well as obesity.Given the size of the genomic interval spanned by this gene, it is conceivable that the large intronic regions harbor some regulatory elements that have not been uncovered and may be specific to humans.
36
Future Work
Over the past years, some synthetic inhibitors of PTP-1βhave been reported that can be used to reduce or inhibit the activity of the phosphatase. These inhibitors may offer a new approach to treating hypertension or dyslipidemiain Chinese or Japanese.
37
Design of Future Clinical Trials
Tailor made medicines Drug responder and non-responder Global study– Perspective clinical trials of the safety and efficacy of
test drugs may be conducted to study the inter-individual and cross-ethnic variation in drug response.
top related